Literature DB >> 2104177

Immunological abnormalities in a group of patients with limited cutaneous systemic sclerosis and prominent vascular disease.

A Passaleva1, G Massai, M Matucci-Cerinic, M P Domeneghetti, J Sharifian, T Lotti, M Cagnoni, M Ricci.   

Abstract

Antinuclear antibodies, circulating immune complexes, rheumatoid factors and anticardiolipin antibodies were detected in the sera of 17 patients affected by the limited cutaneous subset of systemic sclerosis and marked clinical evidence of ischaemic cutaneous lesions (fingertip ulcerations). This study was designed to evaluate the possible role of anticardiolipin (aCL) antibodies and other immunological disorders in the endothelial damage characteristic of the disease. ACL antibodies were found in 41% of the patients. With the exception of a significant connection with positive rheumatoid factor tests (RIA), no notable associations between anticardiolipin antibodies and antinuclear antibodies, circulating immune complexes (CIC), and other serological abnormalities were found. ACL antibodies did not significantly correlate with the presence of vascular lesions in our patients. However, a role of these antibodies in endothelial damage cannot be excluded, possibly in association with other serum factors such as immune complexes and antinuclear antibodies. A positive connection between the incidence of CIC and the severity of lung perfusion impairment was observed, and the previously reported relationship between anticentromere antibodies and calcinosis was indirectly confirmed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2104177     DOI: 10.3109/08916939008998420

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  3 in total

1.  Anticardiolipin, anticentromere and anti-Scl-70 antibodies in patients with systemic sclerosis and severe digital ischaemia.

Authors:  A L Herrick; M Heaney; S Hollis; M I Jayson
Journal:  Ann Rheum Dis       Date:  1994-08       Impact factor: 19.103

2.  Vasculitis in patients with systemic sclerosis and severe digital ischaemia requiring amputation.

Authors:  A L Herrick; P K Oogarah; A J Freemont; R Marcuson; M Haeney; M I Jayson
Journal:  Ann Rheum Dis       Date:  1994-05       Impact factor: 19.103

Review 3.  The clinical relevance of autoantibodies in scleroderma.

Authors:  Khanh T Ho; John D Reveille
Journal:  Arthritis Res Ther       Date:  2003-02-12       Impact factor: 5.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.